HomeCompareKNBIF vs CL

KNBIF vs CL: Dividend Comparison 2026

KNBIF yields 9090.91% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KNBIF wins by $21569447714287804.00M in total portfolio value
10 years
KNBIF
KNBIF
● Live price
9090.91%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21569447714287804.00M
Annual income
$21,112,599,253,241,626,000,000.00
Full KNBIF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — KNBIF vs CL

📍 KNBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKNBIFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KNBIF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KNBIF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KNBIF
Annual income on $10K today (after 15% tax)
$772,727.27/yr
After 10yr DRIP, annual income (after tax)
$17,945,709,365,255,380,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, KNBIF beats the other by $17,945,709,365,255,380,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KNBIF + CL for your $10,000?

KNBIF: 50%CL: 50%
100% CL50/50100% KNBIF
Portfolio after 10yr
$10784723857143902.00M
Annual income
$10,556,299,626,620,813,000,000.00/yr
Blended yield
97.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

KNBIF
No analyst data
Altman Z
-21.3
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KNBIF buys
0
CL buys
0
No recent congressional trades found for KNBIF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKNBIFCL
Forward yield9090.91%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$21569447714287804.00M$40.8K
Annual income after 10y$21,112,599,253,241,626,000,000.00$5,401.96
Total dividends collected$21538997001133020.00M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KNBIF vs CL ($10,000, DRIP)

YearKNBIF PortfolioKNBIF Income/yrCL PortfolioCL Income/yrGap
1← crossover$919,791$909,090.91$11,012$312.01+$908.8KKNBIF
2$79,131,237$78,147,061.10$12,196$412.95+$79.12MKNBIF
3$6,367,969,272$6,283,298,848.49$13,599$549.66+$6367.96MKNBIF
4$479,373,708,687$472,559,981,565.83$15,288$736.64+$479373.69MKNBIF
5$33,759,466,880,937$33,246,537,012,641.96$17,353$995.28+$33759466.86MKNBIF
6$2,224,307,476,184,878$2,188,184,846,622,275.00$19,926$1,357.80+$2224307476.16MKNBIF
7$137,120,917,193,402,000$134,740,908,193,884,210.00$23,194$1,873.82+$137120917193.38MKNBIF
8$7,909,629,907,685,076,000$7,762,910,526,288,135,000.00$27,439$2,621.52+$7909629907685.05MKNBIF
9$426,961,178,547,826,460,000$418,497,874,546,603,460,000.00$33,088$3,727.38+$426961178547826.38MKNBIF
10$21,569,447,714,287,803,000,000$21,112,599,253,241,626,000,000.00$40,806$5,401.96+$21569447714287804.00MKNBIF

KNBIF vs CL: Complete Analysis 2026

KNBIFStock

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Full KNBIF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this KNBIF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KNBIF vs SCHDKNBIF vs JEPIKNBIF vs OKNBIF vs KOKNBIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.